R&D Systems™ Recombinant Mouse PIR-B Protein, CF

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Supplier:  R&D Systems™ 2754PB050

Catalog No. 27-54P-B050

Description

Measured by its binding ability in a functional ELISA. When biotinylated recombinant rat MAG/Siglec-4a Fc Chimera is catured on Streptavidin coated plate (Catalog # CP003 ), Recombinant Mouse PIR-B binds with an apparent Kd < 100 nM.

Specifications

• Accession Number: AAG01012
• Formulation: Lyophilized from a 0.2 µm filtered solution in PBS with trehalose
• Molecular Weight (g/mol): M.W. (Observed): 85-95 kDa, reducing conditions; M.W. (theoretical): 69 kDa
• Preparation Method: Reconstitute at 250μg/mL in sterile PBS.
• Quality Control Testing: SDS-PAGE: 85-95kDa, reducing conditions
• Source: Mouse myeloma cell line, NS0-derived mouse PIR-B protein Gly24-Gly635, with a C-terminal 6-His tag
• Regulatory Status: RUO
• Without Additives: Carrier Protein
• Gene Symbol: Pirb
• Recombinant: Yes
• Protein: PIR-B

• For Use With (Application): Bioactivity
• Gene ID (Entrez): 11025
• Name: PIR-B
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain
• Quantity: 50 µg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Termination: Gly24
• Endotoxin Concentration: <0.10 EU / 1 µg of the protein by the LAL method.
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 250 µg/mL in sterile PBS.

Safety and Handling

ShelfLife : 365 days